Day: 21 February 2024

  • Pathways to Approval : Navigating EU Pharmaceutical Regulation through CP and DCP

    Pathways to Approval : Navigating EU Pharmaceutical Regulation through CP and DCP

    —

    by

    Elliogen
    in

    Introducing a pharmaceutical product into the European Union (EU) necessitates a thorough understanding of the regulatory pathways for obtaining marketing authorization. This is a critical step for pharmaceutical companies aiming to successfully navigate the complex regulatory framework of the EU. There are two principal pathways to consider: the Centralised Procedure (CP) and the Decentralised Procedure…